logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-3. New clients entering treatment by primary drug, 1998 to 2008 [see all tables in this series...]

Part (iv) New cannabis clients by country and year of treatment (%)

Country19981999200020012002200320042005200620072008
Belgium(1)37.634.3:::::36.0:::
Bulgaria2.22.51.33.24.75.06.99.33.72.04.0
Czech Republic16.316.722.017.622.723.621.620.418.318.019.0
Denmark26.031.030.033.039.344.146.648.350.551.655.9
Germany37.740.042.645.048.050.756.458.056.149.857.4
Estonia::::::::::3.4
Ireland24.425.635.438.245.545.141.540.035.728.130.8
Greece10.010.76.510.711.011.710.510.111.612.213.0
Spain12.511.914.516.922.321.216.318.520.1:
France:25.6:::35.9:62.662.065.365.0
Italy7.67.98.08.29.110.323.823.818.415.616.4
Cyprus29.630.530.032.340.243.341.248.2
Latvia17.09.99.311.720.222.119.716.010.811.816.8
Lithuania0.20.30.70.31.51.60.4
Luxembourg(2)5.010.010.017.011.08.05.44.91.95.60.6
Hungary(3)13.612.914.419.114.125.249.452.454.177.976.6
Malta(4)0.00.70.00.71.03.50.818.319.0::
Netherlands25.424.628.524.627.932.038.241.843.345.046.6
Austria(5)0.00.00.00.00.00.00.00.034.834.135.7
Poland(6)1.82.42.93.03.44.4:::::
Portugal:3.42.5::10.611.76.810.810.910.5
Romania:::1.22.34.03.04.35.611.69.7
Slovenia(7)8.410.814.312.722.718.319.610.29.16.56.6
Slovakia9.09.711.812.217.923.825.228.826.927.122.9
Finland31.032.736.241.239.638.142.031.74127.926.8
Sweden(8)19.424.627.130.031.431.530.428.134.0
United Kingdom(9)9.010.09.09.09.017.018.021.924.825.127.2
Croatia::::::::34.931.236.1
Turkey::::::29.228.550.846.436.6
Norway:::::::::::

Notes:

 (1) 2000 data were available but they were not included due to a lack of comparability. 1998 data refers to opioids in general. 2005 data only refers to outpatient and low-threshold agencies and do not cover Brussels Capital Region. 

 (2) Data refer to all treatments.                         

 (3) From 2003 a new, quasi compulsory treatment (diversion) became available for drug offenders (meeting the requirements) as an alternative for criminal prosecution. As these cases give the majority of clients entering treatment for the first time in their lives from 2004 and the composition of clients in diversion differs from regular clients it especially changes the composition of all clients entering treatment for the first time in their lives. The source of the data has changed in 2007: from “Hungarian National Focal Point – National statistical programme” (1997-2006) to “Hungarian National Focal Point – TDI data collection” (2007). The change limits the comparability of the 2007 data to previous data. 

 (4) In order to include time trends, data reported in Table 3 refer to one outpatient centre for which data were available for the whole time period. 

 (5) In the case of Austria, up to 2005 data only refer to clients in substitution treatment, using opioids as primary drug. Since 2006, data are based on new DOKLI data collection system. 

 (6) Data refer to all treatments up to 2002. For 2003 data refer to first treatments. For 2004-2008, data were not available and therefore not included in the analysis. 

 (7) Data for 2004 includes data for outpatient clients and clients treated in prison. Data for outpatient clients was validated, however data collection for prison clients was still in the process of development, thus figures are underestimated 

 (8) Data before 2000 were available but were not included because of a major change in the reporting systrem, which would have biased the comparison of data over time. The system is under development and every year new units are added to the information system. 2007 data do not cover treatment units in prisons. 

 (9) Data refer to all treatments up to 2002 and to new treatments from 2003. Before 2003, data only refer to amphetamines. 

 See also ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — Standard table 3 and TDI. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 14 July 2010